Northern Trust’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.3M | Buy |
2,720,444
+76,231
| +3% | +$1.09M | 0.01% | 1255 |
|
|
2025
Q4 | $37.7M | Sell |
2,644,213
-693,162
| -21% | -$6.81M | ﹤0.01% | 1286 |
|
|
2025
Q3 | $26.3M | Buy |
3,337,375
+247,569
| +8% | +$1.76M | ﹤0.01% | 1515 |
|
|
2025
Q2 | $17.7M | Sell |
3,089,806
-285,320
| -8% | -$1.84M | ﹤0.01% | 1714 |
|
|
2025
Q1 | $27.5M | Buy |
3,375,126
+3,487
| +0.1% | +$32.3K | ﹤0.01% | 1438 |
|
|
2024
Q4 | $31.8M | Buy |
3,371,639
+187,652
| +6% | +$1.95M | ﹤0.01% | 1416 |
|
|
2024
Q3 | $34M | Buy |
3,183,987
+136,633
| +4% | +$1.49M | 0.01% | 1287 |
|
|
2024
Q2 | $30.2M | Sell |
3,047,354
-108,728
| -3% | -$1.12M | 0.01% | 1297 |
|
|
2024
Q1 | $37.2M | Buy |
3,156,082
+311,331
| +11% | +$3.98M | 0.01% | 1192 |
|
|
2023
Q4 | $40.4M | Buy |
2,844,751
+12,821
| +0.5% | +$146K | 0.01% | 1156 |
|
|
2023
Q3 | $34.4M | Buy |
2,831,930
+15,608
| +0.6% | +$201K | 0.01% | 1177 |
|
|
2023
Q2 | $35.4M | Buy |
2,816,322
+99,488
| +4% | +$1.18M | 0.01% | 1199 |
|
|
2023
Q1 | $30.1M | Buy |
2,716,834
+19,261
| +0.7% | +$237K | 0.01% | 1288 |
|
|
2022
Q4 | $32.9M | Buy |
2,697,573
+33,885
| +1% | +$381K | 0.01% | 1195 |
|
|
2022
Q3 | $27.8M | Sell |
2,663,688
-30,413
| -1% | -$339K | 0.01% | 1246 |
|
|
2022
Q2 | $28.9M | Buy |
2,694,101
+5,461
| +0.2% | +$45K | 0.01% | 1280 |
|
|
2022
Q1 | $25.5M | Sell |
2,688,640
-106,397
| -4% | -$998K | ﹤0.01% | 1505 |
|
|
2021
Q4 | $32.3M | Sell |
2,795,037
-35,963
| -1% | -$401K | 0.01% | 1434 |
|
|
2021
Q3 | $27M | Sell |
2,831,000
-124,285
| -4% | -$1.27M | ﹤0.01% | 1570 |
|
|
2021
Q2 | $28.5M | Sell |
2,955,285
-5,431
| -0.2% | -$53K | 0.01% | 1635 |
|
|
2021
Q1 | $29.3M | Sell |
2,960,716
-265,189
| -8% | -$4.1M | 0.01% | 1555 |
|
|
2020
Q4 | $74.5M | Sell |
3,225,905
-78,592
| -2% | -$1.61M | 0.01% | 800 |
|
|
2020
Q3 | $46.7M | Sell |
3,304,497
-205,250
| -6% | -$2.99M | 0.01% | 968 |
|
|
2020
Q2 | $52.9M | Buy |
3,509,747
+142,231
| +4% | +$1.73M | 0.01% | 849 |
|
|
2020
Q1 | $31.1M | Buy |
3,367,516
+38,667
| +1% | +$368K | 0.01% | 1094 |
|
|
2019
Q4 | $32.4M | Buy |
3,328,849
+70,440
| +2% | +$645K | 0.01% | 1349 |
|
|
2019
Q3 | $26.1M | Buy |
3,258,409
+598,798
| +23% | +$6.5M | 0.01% | 1467 |
|
|
2019
Q2 | $33.2M | Buy |
2,659,611
+136,521
| +5% | +$1.73M | 0.01% | 1315 |
|
|
2019
Q1 | $34.3M | Buy |
2,523,090
+80,700
| +3% | +$986K | 0.01% | 1274 |
|
|
2018
Q4 | $23.4M | Sell |
2,442,390
-3,487
| -0.1% | -$38.3K | 0.01% | 1449 |
|
|
2018
Q3 | $29.6M | Buy |
2,445,877
+51,387
| +2% | +$719K | 0.01% | 1467 |
|
|
2018
Q2 | $37.4M | Buy |
2,394,490
+203,444
| +9% | +$3.08M | 0.01% | 1266 |
|
|
2018
Q1 | $33M | Buy |
2,191,046
+219,558
| +11% | +$3.34M | 0.01% | 1319 |
|
|
2017
Q4 | $28.4M | Sell |
1,971,488
-5,371
| -0.3% | -$73.8K | 0.01% | 1439 |
|
|
2017
Q3 | $29.8M | Buy |
1,976,859
+238,849
| +14% | +$3.16M | 0.01% | 1391 |
|
|
2017
Q2 | $17.5M | Buy |
1,738,010
+52,569
| +3% | +$423K | ﹤0.01% | 1771 |
|
|
2017
Q1 | $12M | Buy |
1,685,441
+71,599
| +4% | +$453K | ﹤0.01% | 1987 |
|
|
2016
Q4 | $8.02M | Buy |
1,613,842
+13,726
| +0.9% | +$95K | ﹤0.01% | 2249 |
|
|
2016
Q3 | $11.8M | Buy |
1,600,116
+164,436
| +11% | +$1.11M | ﹤0.01% | 1954 |
|
|
2016
Q2 | $7.84M | Buy |
1,435,680
+118,138
| +9% | +$826K | ﹤0.01% | 2181 |
|
|
2016
Q1 | $11.1M | Buy |
1,317,542
+19,034
| +1% | +$135K | ﹤0.01% | 1896 |
|
|
2015
Q4 | $12.6M | Buy |
1,298,508
+34,967
| +3% | +$315K | ﹤0.01% | 1832 |
|
|
2015
Q3 | $17.7M | Buy |
1,263,541
+1,019,446
| +418% | +$16M | 0.01% | 1584 |
|
|
2015
Q2 | $3.45M | Buy |
244,095
+78,941
| +48% | +$949K | ﹤0.01% | 2755 |
|
|
2015
Q1 | $1.8M | Buy |
165,154
+18,149
| +12% | +$160K | ﹤0.01% | 3179 |
|
|
2014
Q4 | $1.22M | Buy |
147,005
+58,347
| +66% | +$400K | ﹤0.01% | 3327 |
|
|
2014
Q3 | $528K | Sell |
88,658
-236,266
| -73% | -$1.24M | ﹤0.01% | 3552 |
|
|
2014
Q2 | $1.09M | Sell |
324,924
-76,526
| -19% | -$180K | ﹤0.01% | 3365 |
|
|
2014
Q1 | $831K | Sell |
401,450
-25,142
| -6% | -$62.9K | ﹤0.01% | 3435 |
|
|
2013
Q4 | $1M | Buy |
426,592
+4,358
| +1% | +$9.57K | ﹤0.01% | 3378 |
|
|
2013
Q3 | $979K | Sell |
422,234
-4,264
| -1% | -$10.7K | ﹤0.01% | 3335 |
|
|
2013
Q2 | $993K | Buy |
+426,498
| New | +$1.31M | ﹤0.01% | 3275 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Northern Trust's FOLD Position: Q1 2026 in Review
Northern Trust increased its Amicus Therapeutics (FOLD) stake by 2.9% in Q1 2026, buying an estimated $1.09M and bringing the position to 2,720,444 shares worth $39.3M. The position accounts for 0.01% of the portfolio, ranked #1255.
Northern Trust first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. The position peaked at $74.5M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Northern Trust held 2,720,444 shares of Amicus Therapeutics worth $39.3M as of Q1 2026.
- Northern Trust bought 76,231 Amicus Therapeutics shares in Q1 2026, an estimated $1.09M.
- Amicus Therapeutics made up 0.01% of Northern Trust's portfolio in Q1 2026, its #1255 holding.
- Northern Trust first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Amicus Therapeutics position peaked at $74.5M in Q4 2020.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.